Rapid Micro Biosystems (RPID) is Rebuilding Credibility After an Ill-Conceived Capital Raise

White Brook Capital’s Q3 2026 investor letter expresses cautious optimism. Its Ethical All-Cap Strategy has outperformed, while the Small Cap Strategy has lagged because of execution delays, higher interest rates, and market pressure. You can download a copy of the letter here. The economy remains resilient, supported by AI infrastructure investment, consumer spending, healthcare research, […]